Product
ASC47
1 clinical trial
1 indication
Indication
NASHClinical trial
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 Injection for Subcutaneous Use in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-12-01